Irhythm Technologies Inc. (IRTC)
NASDAQ
Closed
Aug 24, 2026
Day's Range
125.1752 wk Range
100.85Overview - IRTC - Irhythm Technologies Inc.
Key Statistics
Valuation
Enterprise Value
4.37B
P/E (Trailing)
‪-92.50‬
P/E (Forward)
‪105.90‬
PEG Ratio
‪0.94‬
Price / Sales (TTM)
‪5.13‬
Price / Book
‪22.76‬
EV / EBITDA
‪247.10‬
Profitability
Gross Margin
‪72.80%‬
Profit Margin
‪-1.69%‬
Operating Margin
‪7.93%‬
Return on Assets
‪0.64%‬
Return on Equity
‪-9.63%‬
Ownership
Shares Outstanding
32.85M
Float
30.30M
Short % of Shares Outstanding
‪9.84%‬
Held by Insiders
‪1.16%‬
Held by Institutions
‪110.72%‬
Price stats
Beta
‪1.32‬
50-Day Avg
‪117.72‬
200-Day Avg
‪137.40‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
15 analysts
Average price target
‪$ 176.86‬Shariah Compliance
Report Date: Feb 19, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - IRTC - Irhythm Technologies Inc.
Peers - IRTC - Irhythm Technologies Inc.
Peer Comparison
Compared with companies in Medical Devices listed on NASDAQ.
Profile Summary - IRTC - Irhythm Technologies Inc.
About
iRhythm Technologies Inc. is a leading digital healthcare company that develops and commercializes wearable biosensors and cloud-based analytics for detecting, predicting, and preventing cardiac diseases. Its flagship Zio platform features an FDA-cleared, CE-marked, wire-free patch-based biosensor that records up to…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
